Advanced Molecular Diagnostics Enhance Classification of Primary Myelofibrosis
Episode Summary
Advances in molecular diagnostics are improving primary myelofibrosis classification, enabling more precise diagnoses, personalized treatments, and targeted therapies based on patients’ genetic profiles.